User:Rithish Nimmagadda: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 44: Line 44:


#[[Eosinophilic esophagitis medical therapy]]
#[[Eosinophilic esophagitis medical therapy]]
#[[Migraine]]

Revision as of 18:04, 23 June 2024

<nowiki>

Your Name

Rithish Nimmagadda,MBBS

Research scholar
Contact:945-278-1660
Email: rithishnvs@gmail.com [1]

Current Position

  • research scholar (list chapters here)



Education

Medical Degree from Kamineni Academy of Medical sciences and research centre , Hyderabad , India



Pages Authored

  1. Epcoritamab-bysp
  2. Elfabrio
  3. Mirikizumab-mrkz
  4. Bimekizumab
  5. Lotilaner
  6. Quizartinib
  7. Ritlecitinib
  8. Tofersen
  9. Retifanlimab-dlwr
  10. Velmanase alfa-tycv
  11. Elacestrant
  12. Pirtobrutinib
  13. vonoprazan, amoxicillin, and clarithromycin
  14. Iptacopa

Pages Co-authored/Collaborated